{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:54:25Z","timestamp":1790830465327,"version":"4.1.0"},"reference-count":45,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2019,8,27]]},"DOI":"10.3233\/jhd-180333","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T11:30:09Z","timestamp":1564486209000},"page":"257-269","source":"Crossref","is-referenced-by-count":17,"title":["Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington\u2019s Disease"],"prefix":"10.1177","volume":"8","author":[{"given":"Pranav P.","family":"Mathkar","sequence":"first","affiliation":[{"name":"The Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences; Cedars-Sinai Medical Center, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Suresh","sequence":"additional","affiliation":[{"name":"The Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences; Cedars-Sinai Medical Center, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dunn","sequence":"additional","affiliation":[{"name":"The Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences; Cedars-Sinai Medical Center, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colton M.","family":"Tom","sequence":"additional","affiliation":[{"name":"The Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences; Cedars-Sinai Medical Center, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia B.","family":"Mattis","sequence":"additional","affiliation":[{"name":"The Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences; Cedars-Sinai Medical Center, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/JHD-180333_ref1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JHD-180333_ref2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","author":"Walker","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.3233\/JHD-180333_ref3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","article-title":"Psychopathology in verified Huntington\u2019s disease gene carriers","volume":"19","author":"van Duijn","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.3233\/JHD-180333_ref4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: A clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.3233\/JHD-180333_ref5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/WCO.0b013e3282f12074","article-title":"Huntington\u2019s disease phenocopy syndromes","volume":"20","author":"Wild","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JHD-180333_ref6","unstructured":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell. 2015;162(3):516\u201326."},{"issue":"9","key":"10.3233\/JHD-180333_ref7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.7150\/ijbs.9898","article-title":"Preclinical and clinical investigations of mood stabilizers for Huntington\u2019s disease: What have we learned","volume":"10","author":"Scheuing","year":"2014","journal-title":"Int J Biol Sci"},{"issue":"11","key":"10.3233\/JHD-180333_ref8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/mds.26021","article-title":"Clinical trials in Huntington\u2019s disease: Interventions in early clinical development and newer methodological approaches","volume":"29","author":"Sampaio","year":"2014","journal-title":"Mov Disord"},{"issue":"9","key":"10.3233\/JHD-180333_ref9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington\u2019s disease: A systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov Disord"},{"issue":"4-5","key":"10.3233\/JHD-180333_ref10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3727\/096368914X678454","article-title":"Polyglutamine (PolyQ) diseases: Genetics to treatments","volume":"23","author":"Fan","year":"2014","journal-title":"Cell Transplant"},{"issue":"2","key":"10.3233\/JHD-180333_ref11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington\u2019s disease","volume":"19","author":"Zielonka","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.3233\/JHD-180333_ref12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.3233\/JHD-180333_ref13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat Genet"},{"key":"10.3233\/JHD-180333_ref14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2015.10.001","article-title":"Modeling Huntington\u2019s disease with patient-derived neurons","volume":"1656","author":"Mattis","year":"2017","journal-title":"Brain Res"},{"issue":"11","key":"10.3233\/JHD-180333_ref15","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.3233\/JHD-180333_ref16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","article-title":"Apoptosis in Huntington\u2019s disease","volume":"27","author":"Hickey","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"10.3233\/JHD-180333_ref17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: Interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"issue":"51","key":"10.3233\/JHD-180333_ref18","doi-asserted-by":"crossref","first-page":"21900","DOI":"10.1073\/pnas.0912171106","article-title":"Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington\u2019s disease","volume":"106","author":"Molero","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-180333_ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/106529","article-title":"Molecular regulation of striatal development: A review","volume":"2012","author":"Evans","year":"2012","journal-title":"Anat Res Int"},{"issue":"10","key":"10.3233\/JHD-180333_ref20","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington\u2019s disease","volume":"14","author":"Pouladi","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.3233\/JHD-180333_ref21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.stem.2013.05.016","article-title":"Modeling human disease with pluripotent stem cells: From genome association to function","volume":"12","author":"Merkle","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.3233\/JHD-180333_ref22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington\u2019s disease for translation to the clinic: Best practices","volume":"29","author":"Menalled","year":"2014","journal-title":"Mov Disord"},{"issue":"4","key":"10.3233\/JHD-180333_ref23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5858","key":"10.3233\/JHD-180333_ref24","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"issue":"7151","key":"10.3233\/JHD-180333_ref25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","article-title":"Generation of germline-competent induced pluripotent stem cells","volume":"448","author":"Okita","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.3233\/JHD-180333_ref26","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1073\/pnas.1603871113","article-title":"Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington\u2019s disease","volume":"113","author":"Molero","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.3233\/JHD-180333_ref27","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1007\/s12035-017-0477-7","article-title":"Huntington disease as a neurodevelopmental disorder and early signs of the disease in stem cells","volume":"55","author":"Wiatr","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.3233\/JHD-180333_ref28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrneurol.2017.45","article-title":"Human induced pluripotent stem cells for modelling neurodevelopmental disorders","volume":"13","author":"Ardhanareeswaran","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.3233\/JHD-180333_ref29","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1007\/s12035-015-9601-8","article-title":"Induced pluripotent stem cells in Huntington\u2019s disease: Disease modeling and the potential for cell-based therapy","volume":"53","author":"Liu","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.3233\/JHD-180333_ref30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice","volume":"20","author":"HD iPSC Consortium","year":"2017","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.3233\/JHD-180333_ref31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.stemcr.2015.11.005","article-title":"Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human Huntington\u2019s disease neural stem cells","volume":"5","author":"Ring","year":"2015","journal-title":"Stem Cell Rep"},{"issue":"1-2","key":"10.3233\/JHD-180333_ref32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1566-2772(02)00005-1","article-title":"Pre- and post-developmental neurogenesis in primates","volume":"2","author":"Rakic","year":"2002","journal-title":"Clin Neurosci Res"},{"issue":"1-2","key":"10.3233\/JHD-180333_ref33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(99)01757-6","article-title":"Expression of nestin after traumatic brain injury in rat brain","volume":"840","author":"Sahin Kaya","year":"1999","journal-title":"Brain Res"},{"issue":"8","key":"10.3233\/JHD-180333_ref34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1369\/jhc.2010.955609","article-title":"The neural stem\/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature","volume":"58","author":"Suzuki","year":"2010","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"10.3233\/JHD-180333_ref35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2003.08.056","article-title":"Expression of nestin in Purkinje cells in patients with Creutzfeldt-Jakob disease","volume":"352","author":"Mizuno","year":"2003","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.3233\/JHD-180333_ref36","doi-asserted-by":"crossref","first-page":"e64368","DOI":"10.1371\/journal.pone.0064368","article-title":"Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis","volume":"8","author":"Nguyen","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.3233\/JHD-180333_ref37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/exnr.1998.6832","article-title":"Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways","volume":"152","author":"Velier","year":"1998","journal-title":"Exp Neurol"},{"issue":"11","key":"10.3233\/JHD-180333_ref38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrn4021","article-title":"Proliferation control in neural stem and progenitor cells","volume":"16","author":"Homem","year":"2015","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.3233\/JHD-180333_ref39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/er.2006-0046","article-title":"Notch signaling in development and cancer","volume":"28","author":"Bol\u00f3s","year":"2007","journal-title":"Endocrine Rev"},{"issue":"9","key":"10.3233\/JHD-180333_ref40","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.exphem.2016.06.183","article-title":"BLOS2 negatively regulates notch signaling during hematopoietic stem and progenitor cell development in vertebrates","volume":"44","author":"Zhou","year":"2016","journal-title":"Exp Hematol"},{"issue":"7313","key":"10.3233\/JHD-180333_ref41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature09347","article-title":"Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal","volume":"467","author":"Aguirre","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.3233\/JHD-180333_ref42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.neuro.25.030702.130823","article-title":"The role of notch in promoting glial and neural stem cell fates","volume":"25","author":"Gaiano","year":"2002","journal-title":"Annu Rev Neurosci"},{"issue":"6","key":"10.3233\/JHD-180333_ref43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/cell.2017.0009","article-title":"NOTCH signaling is essential for maturation, self-renewal, and tri-differentiation of in vitro derived human neural stem cells. cellular reprogramming.","volume":"19","author":"Venkatesh","year":"2017","journal-title":"Cell Reprogram"},{"issue":"3","key":"10.3233\/JHD-180333_ref44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","article-title":"Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis","volume":"67","author":"Godin","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.3233\/JHD-180333_ref45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1750-1326-5-58","article-title":"Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors","volume":"5","author":"Kegel","year":"2010","journal-title":"Mol Neurodegener"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-180333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:48Z","timestamp":1777452648000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-180333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":45,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jhd-180333","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]}}}